Literature DB >> 25294094

Natural daucane esters induces apoptosis in leukaemic cells through ROS production.

Stefano Dall'Acqua1, Maria Antonella Linardi2, Roberta Bortolozzi2, Maria Clauser3, Sara Marzocchini3, Filippo Maggi4, Marcello Nicoletti5, Gabbriella Innocenti3, Giuseppe Basso2, Giampietro Viola6.   

Abstract

Continuing our research on antiproliferative agents from plants, we extended our interest on further compounds isolated from Ferula communis and Ferulago campestris. One new daucane (DE-20) and one new phenol derivative (PH-3) were isolated and characterized in addition to six daucane, three coumarins and four simple phenolics. The cytotoxic activity was evaluated against a panel of six human tumor cell lines. The derivative DE-17 that resulted moderately active on all the studied cell lines was studied to evaluate its possible mechanism of action. DE-17 was able to induce apoptosis in a time and concentration-dependent manner in SEM and Jurkat cell lines. We observed that DE-17 just after 1h of treatment increased the reactive oxygen species (ROS) production and that the co-incubation of DE-17 with ROS scavengers significantly increased cell viability suggesting that ROS-mediated downstream signaling is essential for the antiproliferative effects of DE-17. At later times of incubation DE-17 induced mitochondrial depolarization, as well as caspase-3 and -9 activation suggesting that apoptosis follow the mitochondrial pathway. Concomitantly to ROS induction, a remarkable decrease of mRNA expression of several antioxidant enzymes and intracellular GSH content was detected in treated cells compared to controls further indicative of oxidative stress. Taken together our results showed for the first time that daucane esters induces apoptotic cell death through a ROS-mediated mechanism in human leukemia cells.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Coumarins; Daucane sesquiterpenes; Ferula communis; Ferulago campestris; Natural compounds; Reactive oxygen species

Mesh:

Substances:

Year:  2014        PMID: 25294094     DOI: 10.1016/j.phytochem.2014.09.001

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  7 in total

Review 1.  Mitochondrial ROS control of cancer.

Authors:  María Del Pilar Sosa Idelchik; Ulrike Begley; Thomas J Begley; J Andrés Melendez
Journal:  Semin Cancer Biol       Date:  2017-04-23       Impact factor: 15.707

Review 2.  The Tumorigenic Roles of the Cellular REDOX Regulatory Systems.

Authors:  Stéphanie Anaís Castaldo; Joana Raquel Freitas; Nadine Vasconcelos Conchinha; Patrícia Alexandra Madureira
Journal:  Oxid Med Cell Longev       Date:  2015-11-22       Impact factor: 6.543

3.  Deguelin induces the apoptosis of lung cancer cells through regulating a ROS driven Akt pathway.

Authors:  Huae Xu; Xiaolin Li; Wenqiu Ding; Xiaoning Zeng; Hui Kong; Hong Wang; Weiping Xie
Journal:  Cancer Cell Int       Date:  2015-02-25       Impact factor: 5.722

Review 4.  The Genus Ferulago: A Review on Ethnopharmacology, Phytochemistry, and Pharmacology.

Authors:  Yahya Rahimpour; Abbas Delazar; Solmaz Asnaashari; Parina Asgharian
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

Review 5.  Review of the traditional uses, phytochemistry, pharmacology and toxicology of giant fennel (Ferula communis L. subsp. communis).

Authors:  Maryam Akaberi; Milad Iranshahy; Mehrdad Iranshahi
Journal:  Iran J Basic Med Sci       Date:  2015-11       Impact factor: 2.699

Review 6.  Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components.

Authors:  Entaz Bahar; Sun-Young Han; Ji-Ye Kim; Hyonok Yoon
Journal:  Cancers (Basel)       Date:  2022-03-12       Impact factor: 6.639

7.  Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC-1 cell apoptosis via activating the mROS-HtrA2/Omi pathways.

Authors:  Jun Wan; Jie Cui; Lei Wang; Kunpeng Wu; Xiaoping Hong; Yulin Zou; Shuang Zhao; Hong Ke
Journal:  Cancer Cell Int       Date:  2018-10-22       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.